Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-24 @ 7:40 PM
NCT ID:
NCT00195403
Eligibility Criteria:
Inclusion Criteria
Rheumatoid Arthritis
* Adults: Treatment of active rheumatoid arthritis (RA) in adults when the response to disease-modifying antirhematic drugs (DMARDs), including MTX, has been inadequate
* Children: Treatment of active polyarticular-course chronic active rheumatoid arthritis in children aged 4 to 17 years who have had an inadequate response to, or whom have proved intolerant of, MTX
Psoriatic Arthritis
\- Active and progressive psoriatic arthritis (PsA) in adults who do not respond adequately to previous DMARDs
Exclusion Criteria
* Patients to whom Enbrel is contraindicated as per the local labeling
* Patients with known hypersensitivity to Enbrel or any component of the product
* Patients with sepsis or risk of sepsis
* Patients with active infections including chronic or localized infections such as tuberculosis. (Treatment of Enbrel should not be initiated.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Study:
NCT00195403
Study Brief:
Protocol Section:
NCT00195403